Although immune checkpoint inhibitors have improved cancer outcomes, their use can trigger autoimmune toxicities affecting essentially any organ system. In the cardiovascular system, these immune-related adverse events can manifest as myocarditis, pericarditis, accelerated atherosclerosis, vasculitis, arrhythmias, and...
Kerry L. Reynolds, A.-C. Villani, Z. Drobni et al.· JACC CardioOncology· 0 citations
Background Fluoropyrimidine-based chemotherapy is associated with cardiovascular events in patients with colorectal cancer, yet validated tools for pre-treatment cardiovascular risk stratification are lacking. Cardiac biomarkers are not routinely incorporated into baseline assessment and prospective evidence supporting...
Bence Prohászka, Zsófia Sándor, T. Ferenci et al.· Frontiers in Cardiovascular...· 0 citations
Esophageal Cancer: Surgical Treatment of Esophageal Cancer
Surgery remains a key part of multimodal esophageal cancer treatment but carries high morbidity and mortality. Early detection of patients unfit for major surgery is essential. We examined if thorough cardiac evaluation can predict surgical operabi...
Tamás Vass, M. Vértes, Stephan Bennemann et al.· Diseases of the esophagus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.